PREX2 and non-small cell lung carcinoma: These results indicate that PREX2 promotes NSCLC cell growth in vitro as the GEF factor of RAC1 to mediate the ERK/MEK axis and the suppressor of PTEN to regulate the PI3K/AKT signaling pathway.